Belgium· BE-AMP-SAM141897-00
Baxil 0,2 %
A chlorhexidine product containing chlorhexidine digluconate, registered in Belgium by BePharBel Manufacturing. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Chlorhexidine is registered in 13 of 19 countries.
Countries holding a registration under ATC A01AB03 (chlorhexidine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Chlorhexidine · ATC A01AB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Chlorhexidine Digluconate
- Manufacturer
- BePharBel Manufacturing
- Country
- Belgium (BE)
- ATC code
- A01AB03
- ATC class
- Chlorhexidine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb1639152
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A01AB03
Chlorhexidine, as other registers publish it.
- SwitzerlandChlorhexamed 0.1%, LösungHaleon Schweiz AG
- SwitzerlandChlorhexamed 0.1%, LösungHaleon Schweiz AG
- GermanyChlorhexamed FluidHaleon Germany Gmbh
- SwitzerlandChlorhexamed forte 0.2%, LösungHaleon Schweiz AG
- SwitzerlandChlorhexamed forte 0.2%, LösungHaleon Schweiz AG
- GermanyChlorhexamed Forte AlkoholfreiHaleon Germany Gmbh
- SwitzerlandChlorhexamed Gel 1%, Gel zur Anwendung in der MundhöhleHaleon Schweiz AG
- GermanyChlorhexamed MundgelHaleon Germany Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b3a2404-00ca-49ab-ab6d-c44b88fa44a3 GET /v1/drugs/6b3a2404-00ca-49ab-ab6d-c44b88fa44a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oromucosal spray, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Baxil 0,2 %",
"name_fr": "Baxil 0,2 %",
"name_nl": "Baxil 0,2 %",
"amp_code": "SAM141897-00",
"strengths": [
"2.0000"
],
"pack_count": 1,
"substances": [
"Chlorhexidine Digluconate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Chlorhexidine",
"authorisation_numbers": [
"BE141897"
]
}See everything about chlorhexidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.